All stock lists
Heidelberg Pharma AG (Deutsche Börse:HPHA.DE)
DE · Delayed Price · Currency is EUR
Healthcare · Biotechnology
2.08-0.07 (-3.26%)
Insider Score
––Not scored
HPHA.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
HPHA.DE Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 |
| Revenue | 1.92 M | 4.34 M | 3.03 M | 21.44 K | 47.13 K | 118.51 K |
| Revenue Growth (YoY) | 3974.60 % | 3566.19 % | 138.66 % | -98.66 % | -96.05 % | -95.75 % |
| Cost of Revenue | 945.68 K | 380.12 K | 374.20 K | 208.64 K | 86.71 K | 51.18 K |
| Gross Profit | 974.68 K | 3.96 M | 2.66 M | -187.20 K | -39.58 K | 67.33 K |
| SG&A Expense | 1.52 M | 1.21 M | 1.57 M | 2.61 M | 1.56 M | 1.83 M |
| R&D Expense | 4.97 M | 2.27 M | 6.07 M | 17.74 M | 7.59 M | 6.84 M |
| Operating Expenses | 6.49 M | 3.52 M | 8.06 M | 20.23 M | 8.66 M | 7.01 M |
| Operating Income | -5.52 M | 444.28 K | -5.40 M | -20.42 M | -8.70 M | -6.94 M |
| Pretax Income | -5.26 M | 1.29 M | -4.28 M | -20.18 M | -8.46 M | -6.65 M |
| Tax Provision | -140.00 | 425.14 K | 0.00 | 1.05 M | 0.00 | 0.00 |
| Net Income | -5.26 M | 862.76 K | -4.28 M | -21.23 M | -8.46 M | -6.65 M |
| EPS (Basic) | -0.12 | 0.02 | -0.09 | -0.45 | -0.18 | -0.14 |
| EPS (Diluted) | -0.12 | 0.02 | -0.09 | -0.45 | -0.18 | -0.14 |
| Shares Outstanding | 44.95 M | 46.78 M | 47.50 M | 46.78 M | 47.15 M | 46.60 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.